Isoform-selective Anti-TGF-beta antibodies and methods of use
MYPI2026002266A0Undetermined Publication Date: 2021-09-19GENENTECH INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2026002266
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2020-06-26
- Filing Date
- 2021-03-18
- Publication Date
- 2021-09-19
Abstract
The invention provides isoform-selective anti-TGF β antibodies and methods of using the same. In particular, isoform-selective anti-TGF β2, anti-TGF β3, and anti-TGF β 2 / 3 monoclonal antibodies are provided, e.g., for the treatment of fibrosis and other TGF β-related disorders. (FIG. 3A)
Need to check novelty before this filing date? Find Prior Art
